EUVIMEDEUVIMED entdecken
Leitlinie

Adherence to antiemetic prophylaxis guidelines and the association with nausea/vomiting occurrence in breast cancer patients undergoing chemotherapy

Tran Thi Thu Trang, Nguyen Thi Lien Huong, Nguyen Tu Son, Nguyen Huong Giang, Hoang Thi Minh Thu, Vu Dinh Tien, Nguyen Thi Hong Hanh

Tạp chí Nghiên cứu Dược và Thông tin Thuốc · 23.06.2026

DOI: 10.59882/1859-364x/407 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Tạp chí Nghiên cứu Dược và Thông tin Thuốc, online erschienen am 23.06.2026. Verfasst von Tran Thi Thu Trang und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to examine the level of adherence to chemotherapy-induced nausea and vomiting (CINV) prophylaxis guidelines and its association with CINV occurrence at K Hospital. We conducted a prospective cohort study in breast cancer patients undergoing chemotherapy. Medication data for one treatment cycle were extracted from medical records to assess adherence to CINV prophylaxis guidelines based on international (NCCN 2024, ESMO 2016) and national (MOH 2019) recommendations. CINV events and associated risk factors were collected through structured patient interviews, while symptom occurrence and severity were assessed using the MASCC Antiemesis Tool (MAT). A multivariate logistic regression model was used to examine the association between guideline adherence and CINV risk, adjusted for patient characteristics. 118, 61, and 40 patients received high (HEC), medium (MEC), and low emetic chemotherapy (LEC), respectively. The overall incidence of CINV was 30.6% in the acute phase and 63.9% in the delayed phase. In the acute phase, 100% of HEC patients received under-prophylaxis, while 95% of LEC patients received over-prophylaxis. For delayed CINV prophylaxis, 84.7% of HEC patients received under-prophylaxis, and a majority of MEC patients had no prophylaxis (65.6%) or were under-prophylaxis (13.1%). Under-prophylaxis in the acute phase significantly increased the risk of acute CINV (OR [95% CI] 84.810 [10.122-710.0]; p

Zitieren

APA

Trang, T. T. T., Huong, N. T. L., Son, N. T., Giang, N. H., Thu, H. T. M., Tien, V. D., & Hanh, N. T. H. (2026). Adherence to antiemetic prophylaxis guidelines and the association with nausea/vomiting occurrence in breast cancer patients undergoing chemotherapy. Tạp chí Nghiên cứu Dược và Thông tin Thuốc. https://doi.org/10.59882/1859-364x/407

Vancouver

Trang TTT, Huong NTL, Son NT, Giang NH, Thu HTM, Tien VD, et al. Adherence to antiemetic prophylaxis guidelines and the association with nausea/vomiting occurrence in breast cancer patients undergoing chemotherapy. Tạp chí Nghiên cứu Dược và Thông tin Thuốc. 2026. doi:10.59882/1859-364x/407

BibTeX
@article{Trang2026,
  author = {Trang, Tran Thi Thu and Huong, Nguyen Thi Lien and Son, Nguyen Tu and Giang, Nguyen Huong and Thu, Hoang Thi Minh and Tien, Vu Dinh and Hanh, Nguyen Thi Hong},
  title = {Adherence to antiemetic prophylaxis guidelines and the association with nausea/vomiting occurrence in breast cancer patients undergoing chemotherapy},
  journal = {Tạp chí Nghiên cứu Dược và Thông tin Thuốc},
  year = {2026},
  doi = {10.59882/1859-364x/407}
}
Kostenlos starten →